Pursuant to Regulation 29 read with Regulation 47 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, GKB Ophthalmics has informed that a Meeting of the Board of Directors of the Company will be held on Wednesday, May 27, 2026 at the Registered Office of the Company, to consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31, 2026. The Notice can be accessed at the Company's website at www.gkb.net. Further, with reference to the above meeting of the Board of Directors that the Trading Window for dealing with equity shares of the Company, by designated persons, under the SEBI (Prohibition of Insider Trading) Regulations, 2015, had been closed from April 01, 2026, will now re-open after the completion of 48 hours from the date of submission of financial results to the Stock Exchange. This communication has been sent to all the Directors and all the designated employees of the Company.

The above information is a part of company’s filings submitted to BSE.